[1] Bruce, V., Bailine, S., Petrides, G., et al. (2003). Indications for the use of propofol in electroconvulsive therapy. Journal of ECT, 19, 129-132. doi:10.1097/00124509-200309000-00002
[2] Birmaher, B., Brent, D., et al. (1998). Summary of the practice parameters for the assessment and treatment of children and adolescents with depressive disorders. Journal of the American Academy of Child & Adolescent Psychiatry, 37, 1234-1238. doi:10.1097/00004583-199811000-00029
[3] Boylan, L., Haskett, R., et al. (2000). Determinants of seizure threshold in ECT: Benzodiazepine use, anesthetic dosage, and other factors. Journal of ECT, 16, 3-18. doi:10.1097/00124509-200003000-00002
[4] Calarge, C., Crowe, R., et al. (2003). The comparative effects of sevoflurane and methohexital for electroconvulsive therapy. Journal of ECT, 19, 221. doi:10.1097/00124509-200312000-00008
[5] Chanpattana, W. (2001). Anesthesia for ECT. German Journal of Psychiatry, 4, 33-39.
[6] Choudhury, M., Kapoor, P., et al. (2010). A randomized trial of anesthetic induction agents in patients with coronary artery disease and left ventricular dysfunction. Annals of Cardiac Anaesthesia, 13, 217. doi:10.4103/0971-9784.69057
[7] Conway, C., & Nelson L. (2001). The combined use of bupropion, lithium, and venlafaxine during ECT: A case of prolonged seizure activity. Journal of ECT, 17, 216-218. doi:10.1097/00124509-200109000-00014
[8] Ding, Z., & White, P. (2002). Anesthesia for electroconvulsive therapy. Anesthesia & Analgesia, 94, 1351-1364. doi:10.1097/00000539-200205000-00057
[9] Dolenc, T., & Rasmussen, K. (2005). The safety of electroconvulsive therapy and lithium in combination: A case series and review of the literature. Journal of ECT, 21, 165-170. doi:10.1097/01.yct.0000174383.96517.77
[10] Eranti, S., Mogg, A., et al. (2009). Methohexitone, propofol and etomidate in electroconvulsive therapy for depression: A naturalistic comparison study. Journal of Affective Disorders, 113, 165-171. doi:10.1016/j.jad.2008.03.004
[11] Folk, J., Kellner, C., et al. (2000). Anesthesia for electroconvulsive therapy: A review. Journal of ECT, 16, 157-170. doi:10.1097/00124509-200006000-00007
[12] Hiatt, N. (1963). Comparative results of methohexital sodium and thiopental sodium used during out-patient general anesthesia (A doubleblind study). Journal of the American Dental Society of Anesthesiology, 10, 94.
[13] Hooten, W., & Rasmussen K. (2008). Effects of general anesthetic agents in adults receiving electroconvulsive therapy: A systematic review. J ECT, 24, 208-223. doi:10.1097/YCT.0b013e31815bfe2a
[14] Hoshi, H., Kadoi, Y., et al. (2011). Use of rocuronium-sugammadex, an alternative to succinylcholine, as a muscle relaxant during electroconvulsive therapy. Journal of Anesthesia, 25, 286-290. doi:10.1007/s00540-011-1095-6
[15] Jabre, P., Combes, X., et al. (2009). Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: A multicentre randomised controlled trial. The Lancet, 374, 293-300. doi:10.1016/S0140-6736(09)60949-1
[16] Janis, K., Hess, J., et al. (1995). Substitution of mivacurium for succinylcholine for ECT in elderly patients. Canadian Journal of Anesthesia/Journal canadien d’anesthésie, 42, 612-613. doi:10.1007/BF03011879
[17] Kenning, T., Mago, R., et al. (2012). Electroconvulsive therapy: A review of its current status. Jefferson Journal of Psychiatry, 19, 1.
[18] Kellner, C., & Bryson, E. (1998). Anesthesia advances add to safety of ECT. Psychiatric Times, 29, 16-18.
[19] Mayo, C., Kaye, A., et al. (2010). Update on anesthesia considerations for electroconvulsive therapy. Middle East Journal of Anesthesiology, 20, 493-498.
[20] Morgan, C., Curran, H., et al. (2012). Ketamine use: A review. Addiction, 107, 27-38. doi:10.1111/j.1360-0443.2011.03576.x
[21] Rasmussen, K., Jarvis, M., et al. (1996). Ketamine anesthesia in electroconvulsive therapy. Journal of ECT, 12, 217-223.
[22] Rasmussen, K., Jarvis, M., et al. (1999). Low-dose atropine in electroconvulsive therapy. Journal of ECT, 15, 213-221. doi:10.1097/00124509-199909000-00006
[23] Saito, S. (2005). Anesthesia management for electroconvulsive therapy: Hemodynamic and respiratory management. Journal of Anesthesia, 19, 142-149. doi:10.1007/s00540-004-0288-7
[24] Schak, K., Mueller, P., et al. (2008). The safety of ECT in patients with chronic obstructive pulmonary disease. Psychosomatics, 49, 208-211. doi:10.1176/appi.psy.49.3.208
[25] Spitalnic, S., Blazes, C., et al. (2000). Conscious sedation: A primer for outpatient procedures. Hospital Physician, 36, 22-32.
[26] Taylor, S. (2007). Electroconvulsive therapy: A review of history, patient selection, technique, and medication management. Southern Medical Journal, 100, 494-498. doi:10.1097/SMJ.0b013e318038fce0
[27] Uppal, V., Dourish, J., et al. (2010). Anaesthesia for electroconvulsive therapy. Continuing Education in Anaesthesia, Critical Care & Pain, 10, 192-196. doi:10.1093/bjaceaccp/mkq039
[28] Wagner, K., Mollenberg, O., et al. (2005). Guide to anaesthetic selection for electroconvulsive therapy. CNS Drugs, 19, 745-747. doi:10.2165/00023210-200519090-00002
[29] Walder, B., Seeck, M., et al. (2001). Propfol versus methohexital for electroconvulsive therapy: A meta-analysis. Journal of Neurosurgical Anesthesiology, 13, 93-98. doi:10.1097/00008506-200104000-00005
[30] Figiel, G., DeLeo, B., et al. (1993). Combined use of labetalol and nifedipine in controlling the cardiovascular response from ECT. Journal of Geriatric Psychiatry and Neurology, 6, 20-24.
[31] Zhang, Y., White, P., et al. (2005). The use of nicardipine for electroconvulsive therapy: A dose-ranging study. Anesthesia & Analgesia, 100, 378-381. doi:10.1213/01.ANE.0000144419.44481.59